Ubs Oconnor LLC Intra Cellular Therapies, Inc. Transaction History
Ubs Oconnor LLC
- $1.44 Billion
- Q1 2025
A detailed history of Ubs Oconnor LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 3,091,133 shares of ITCI stock, worth $408 Million. This represents 28.36% of its overall portfolio holdings.
Number of Shares
3,091,133Holding current value
$408 Million% of portfolio
28.36%Shares
4 transactions
Others Institutions Holding ITCI
# of Institutions
419Shares Held
68.1MCall Options Held
934KPut Options Held
758K-
Vanguard Group Inc Valley Forge, PA9.52MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.06MShares$403 Million2.32% of portfolio
-
Deep Track Capital, LP Greenwich, CT2MShares$264 Million9.22% of portfolio
-
Geode Capital Management, LLC Boston, MA1.83MShares$242 Million0.02% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...